Clinical characteristics and molecular markers predicting the development and outcome of breast cancer brain metastases.

被引：0
|
作者：
Melisko, ME [1 ]
Chew, K [1 ]
Baehner, F [1 ]
Moore, D [1 ]
Sneed, PK [1 ]
Rugo, HS [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival
    Melisko, Michelle E.
    Moore, Dan H.
    Sneed, Penny K.
    De Franco, Julia
    Rugo, Hope S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) : 359 - 365
  • [32] Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival
    Michelle E. Melisko
    Dan H. Moore
    Penny K. Sneed
    Julia De Franco
    Hope S. Rugo
    [J]. Journal of Neuro-Oncology, 2008, 88 : 359 - 365
  • [33] STAT3 EXPRESSION IN BRAIN METASTASES FROM BREAST CANCER: CORRELATIONS WITH DIFFERENT MOLECULAR SUBTYPES AND CLINICAL OUTCOME
    Pellerino, Alessia
    Bruno, Francesco
    Bertero, Luca
    Bellini, Elisa
    Beano, Alessandra
    Montemurro, Filippo
    Valiente, Manuel
    Ruda, Roberta
    Soffietti, Riccardo
    [J]. NEURO-ONCOLOGY, 2022, 24 : 270 - 270
  • [34] STAT3 EXPRESSION IN BRAIN METASTASES FROM BREAST CANCER: CORRELATIONS WITH DIFFERENT MOLECULAR SUBTYPES AND CLINICAL OUTCOME
    Pellerino, A.
    Bruno, F.
    Mo, F.
    Bertero, L.
    Bellini, E.
    Beano, A.
    Montemurro, F.
    Valiente, M.
    Ruda, R.
    Soffietti, R.
    [J]. NEURO-ONCOLOGY, 2022, 24
  • [35] Clinical Characteristics and Survival Analysis of Breast Cancer Molecular Subtypes with Hepatic Metastases
    Ge, Qi-Dong
    Lv, Ning
    Kong, Ya-Nan
    Xie, Xin-Hua
    He, Ni
    Xie, Xiao-Ming
    Wei, Wei-Dong
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5081 - 5086
  • [36] Clinical and molecular complexity of breast cancer metastases
    Kimbung, Siker
    Loman, Niklas
    Hedenfalk, Ingrid
    [J]. SEMINARS IN CANCER BIOLOGY, 2015, 35 : 85 - 95
  • [37] Distinct immune and molecular features of melanoma brain metastases.
    Davies, Michael A.
    [J]. CANCER RESEARCH, 2020, 80 (19) : 18 - 18
  • [38] The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases.
    Dhesy-Thind, SK
    Julian, J
    Tozer, R
    Ellis, P
    Arnold, A
    Singh, G
    Levine, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 240S - 240S
  • [39] Gemcitabine plus cisplatin patients with heavily pretreated advanced breast cancer with brain metastases.
    Gorbunova, V. A.
    Bychkov, M. B.
    Naskhletashvili, D. R.
    Chmutin, G. E.
    Karahan, V. B.
    Aloshin, V. A.
    Moskvina, E. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases.
    Khatri, Ishaani S.
    Eichholz, Jordan
    Boe, Lillian A.
    Safonov, Anton
    Smith, Deborah Ruth
    Ferraro, Emanuela
    Shen, Junchao
    Imber, Brandon S.
    Yu, Yao
    Yamada, Yoshiya
    Miao, Emily
    Moss, Nelson S.
    Wilcox, Jessica
    Walch, Henry S.
    Chatila, Walid Khaled
    Schultz, Nikolaus
    Razavi, Pedram
    Pike, Luke R. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345